Tenaya Therapeutics, Inc. TNYA
Set alert
0.36 USD -0.01 -1.74%
At close
0.36 0.00 +0.19%
Pre-market · Nov 3, 4:45 AM ET
0.361 Day range 0.3811
0.36 52-week range 1.56
- YTD
- -49.30%
- 1 year
- -74.93%
- Open
- 0.3716
- Prev close
- 0.3674
- Mkt cap
- 82.28M
- Vol
- 2.29M
- Avg vol
- 2.78M
- EPS
- -0.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.361
- High
- 0.3811
- Forward P/E
- -1.28
- Beta
- 2.35
- Short ratio
- 2.31
- Inst. own
- 73.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.40
- 200-d avg
- 3.26
- 1y target
- 18.50
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 18.50 +5024.7% upside
Now 0.361
- Target (low)
- 6.00
- Target (mean)
- 18.50
- Target (high)
- 40.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
- Strong buy3
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.315 | -0.35 – -0.28 | -0.40 | +21.3% | 0 | 0.0% | 8 |
| Next quarter | -0.33 | -0.36 – -0.30 | -0.40 | +17.5% | 0 | 0.0% | 3 |
| Current year | -1.33 | -1.39 – -1.11 | -1.68 | +21.1% | 0 | 0.0% | 8 |
| Next year | -1.26 | -1.42 – -0.91 | -1.33 | +5.2% | 3.29M | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 7, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 18, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 10, 2024 | William Blair | Initiated | — | Outperform |
| May 16, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 21, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Mar 20, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 30, 2023 | Leerink Partners | Initiated | — | Outperform |
| Oct 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Aug 11, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 10, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | Chardan Capital | Maintained | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 9, 2023 | Chardan Capital | Maintained | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 24, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Nov 11, 2022 | Chardan Capital | Maintained | — | Buy |
| Nov 8, 2022 | Canaccord Genuity | Initiated | — | Buy |
| Aug 11, 2022 | Chardan Capital | Maintained | — | Buy |
| Jun 15, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| May 17, 2022 | Morgan Stanley | Maintained | — | Overweight |